1 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow ASIT Biotech S.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis Placebo solution, gpASIT+TM - Hay Fever | Phase 3 | Unknown | ASIT Biotech S.A. | 624 | 2019-01-02 | 2018-10-30 |
| Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients Placebo solution, hdmASIT+TM - House Dust Mite Allergy | Phase 2 | Completed | ASIT Biotech S.A. | 36 | 2016-09-28 | 2017-03-29 |
Dust Mite Allergy (1) · Rhinitis, Allergic, Seasonal (1)
Germany (1)
2016 (1), 2017 (1)